Retirement Systems Of Alabama United Therapeutics Corp Transaction History

Retirement Systems Of Alabama

  • $26.4 Billion
  • Q4 2024

A detailed history of Retirement Systems Of Alabama transactions in United Therapeutics Corp stock. As of the latest transaction made, Retirement Systems Of Alabama holds 129,611 shares of UTHR stock, worth $44.8 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
129,611
Previous 129,372 0.18%
Holding current value
$44.8 Million
Previous $46.4 Million 1.36%
% of portfolio
0.17%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025
BUY
$348.66 - $410.0 $83,329 - $97,990
239 Added 0.18%
129,611 $45.7 Million
Q3 2024

Dec 06, 2024
SELL
$311.04 - $363.55 $3.88 Million - $4.54 Million
-12,481 Reduced 8.8%
129,372 $46.4 Million
Q2 2024

Jul 24, 2024
SELL
$228.26 - $319.04 $973,757 - $1.36 Million
-4,266 Reduced 2.92%
141,853 $45.2 Million
Q1 2024

Apr 30, 2024
BUY
$210.76 - $249.51 $809,107 - $957,868
3,839 Added 2.7%
146,119 $33.6 Million
Q4 2023

Feb 05, 2024
BUY
$214.88 - $256.94 $38,463 - $45,992
179 Added 0.13%
142,280 $31.3 Million
Q3 2023

Nov 06, 2023
SELL
$211.82 - $248.24 $375,133 - $439,633
-1,771 Reduced 1.23%
142,101 $32.1 Million
Q2 2023

Jul 31, 2023
BUY
$205.19 - $232.99 $2.53 Million - $2.87 Million
12,320 Added 9.37%
143,872 $31.8 Million
Q1 2023

May 01, 2023
SELL
$212.99 - $276.17 $110,328 - $143,056
-518 Reduced 0.39%
131,552 $29.5 Million
Q4 2022

Feb 06, 2023
SELL
$205.95 - $280.43 $271,442 - $369,606
-1,318 Reduced 0.99%
132,070 $36.7 Million
Q3 2022

Nov 04, 2022
SELL
$203.3 - $244.17 $17,687 - $21,242
-87 Reduced 0.07%
133,388 $27.9 Million
Q2 2022

Aug 03, 2022
BUY
$174.81 - $241.14 $101,564 - $140,102
581 Added 0.44%
133,475 $31.5 Million
Q1 2022

Apr 20, 2022
BUY
$166.16 - $213.96 $2.01 Million - $2.59 Million
12,119 Added 10.03%
132,894 $23.8 Million
Q4 2021

Jan 20, 2022
BUY
$184.32 - $216.08 $11.5 Million - $13.5 Million
62,649 Added 107.78%
120,775 $26.1 Million
Q3 2021

Nov 03, 2021
SELL
$179.86 - $214.88 $41,907 - $50,067
-233 Reduced 0.4%
58,126 $10.7 Million
Q2 2021

Jul 21, 2021
BUY
$170.47 - $211.93 $36,991 - $45,988
217 Added 0.37%
58,359 $10.5 Million
Q1 2021

Apr 15, 2021
BUY
$153.94 - $174.85 $32,943 - $37,417
214 Added 0.37%
58,142 $9.73 Million
Q4 2020

Jan 26, 2021
SELL
$101.87 - $151.79 $5,500 - $8,196
-54 Reduced 0.09%
57,928 $8.79 Million
Q3 2020

Oct 20, 2020
BUY
$99.9 - $121.13 $55,144 - $66,863
552 Added 0.96%
57,982 $5.86 Million
Q2 2020

Jul 23, 2020
BUY
$92.74 - $125.82 $26,801 - $36,361
289 Added 0.51%
57,430 $6.95 Million
Q4 2019

Jan 28, 2020
BUY
$78.31 - $95.34 $10,963 - $13,347
140 Added 0.25%
57,141 $5.03 Million
Q3 2019

Oct 30, 2019
BUY
$74.85 - $85.99 $1,197 - $1,375
16 Added 0.03%
57,001 $4.55 Million
Q2 2019

Jul 09, 2019
BUY
$76.06 - $120.81 $5,324 - $8,456
70 Added 0.12%
56,985 $4.45 Million
Q1 2019

Apr 15, 2019
BUY
$107.15 - $126.84 $43,181 - $51,116
403 Added 0.71%
56,915 $6.68 Million
Q4 2018

Jan 10, 2019
BUY
$101.4 - $128.73 $21,699 - $27,548
214 Added 0.38%
56,512 $6.15 Million
Q3 2018

Oct 24, 2018
SELL
$113.81 - $129.46 $9,901 - $11,263
-87 Reduced 0.15%
56,298 $7.2 Million
Q2 2018

Jul 17, 2018
BUY
$101.14 - $118.31 $46,726 - $54,659
462 Added 0.83%
56,385 $6.38 Million
Q1 2018

Apr 27, 2018
BUY
$107.21 - $151.94 $5,146 - $7,293
48 Added 0.09%
55,923 $6.28 Million
Q4 2017

Feb 08, 2018
SELL
$118.58 - $151.28 $3.01 Million - $3.84 Million
-25,379 Reduced 31.23%
55,875 $8.27 Million
Q3 2017

Nov 06, 2017
BUY
$114.6 - $136.81 $9.31 Million - $11.1 Million
81,254
81,254 $9.52 Million

Others Institutions Holding UTHR

# of Institutions
692
Shares Held
60.7M
Call Options Held
194K
Put Options Held
292K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $15.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Retirement Systems Of Alabama Portfolio

Follow Retirement Systems Of Alabama and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email